Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s entry into the Indian market. Semaglutide, which is sold under the brand name Wegovy,

Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes that its position as a market leader for insulin products in the country could give it an edge.

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing what appears to be a strategic "something for everyone" plan of attack from the pharmaceutical giant.